Medifast
Stock Forecast, Prediction & Price Target

Medifast Financial Estimates

Medifast Revenue Estimates

Medifast EBITDA Estimates

Medifast Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025
Revenue
 
% change YoY
$1.52B
 
N/A
$1.59B
 
4.75%
$1.07B
 
-32.93%
Avg: $655.35M
Low: $641.35M
High: $669.34M
avg. -38.86%
Net Income
 
% change YoY
$164.03M
 
N/A
$143.56M
 
-12.47%
$99.41M
 
-30.75%
Avg: $17.15M
Low: $16.70M
High: $17.47M
avg. -82.74%
EBITDA
 
% change YoY
$223.05M
 
N/A
$195.78M
 
-12.22%
$139.50M
 
-28.74%
Avg: $87.79M
Low: $85.92M
High: $89.67M
avg. -37.06%
EPS
 
% change YoY
$14.01
 
N/A
$12.82
 
-8.49%
$9.13
 
-28.78%
Avg: $1.57
Low: $1.53
High: $1.6
avg. -82.85%
Operating Expenses
 
% change YoY
$911.35M
 
N/A
$955.60M
 
4.85%
$649.44M
 
-32.03%
Avg: $396.93M
Low: $388.45M
High: $405.40M
avg. -38.88%

FAQ

What is Medifast stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -82.74% in 2025-2025.

We have gathered data from 2 analysts. Their low estimate is 16.70M, average is 17.15M and high is 17.47M.

What is Medifast stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of -38.86% in 2025-2025.

We have gathered data from 1 analysts. Their low revenue estimate is $641.35M, average is $655.35M and high is $669.34M.

What is Medifast stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -82.85% in 2025-2025.

We have gathered data from 2 analysts. Their low earnings per share estimate is $1.53, average is $1.57 and high is $1.6.

What is the best performing analyst?

In the last twelve months analysts have been covering Medifast stock. The most successful analyst is Linda Bolton Weiser whose win rate is 50%. He has correctly predicted 2/4 price targets.